Lannett Company Inc. FDA Record
- Latest inspection VAI · Oct 21, 2022
- 1 Class I recall
- Last warning letter 2009
Lannett Company Inc. has 15 FDA recalls (1 Class I), 21 inspections, 0 510(k) clearances and 1 compliance action on record. FDA has issued 1 warning letter to Lannett Company Inc., the most recent on Mar 30, 2009.
- Latest recall
- D-0660-2026 · Class II · Jun 26, 2026
- Latest inspection
- Oct 21, 2022 · VAI
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 15 (1 Class I) | Nov 11, 2026 (checked Nov 15, 2026, unchanged) | File dated Nov 10, 2026 | Current |
| 510(k) clearances | 0 | Nov 15, 2026 | File dated Nov 9, 2026 | Current |
| Inspections | 21 | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions | 1 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
FDA record by year
Lannett Company Inc.: FDA inspections per year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 0 | 0 | 0 | 3 | 0 |
| 2025 | 0 | 0 | 0 | 3 | 0 |
| 2024 | 0 | 0 | 0 | 1 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 2 | 0 | 0 | 3 | 0 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 | 1 | 0 |
| 2019 | 1 | 0 | 0 | 3 | 1 |
| 2018 | 2 | 0 | 0 | 1 | 0 |
| 2017 | 1 | 0 | 0 | 0 | 0 |
Reviewing Lannett Company Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Lannett Company Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Lannett Company Inc. FDA Warning Letters
| Issued | Subject | Issuing office | Close-out letter |
|---|---|---|---|
| Mar 30, 2009 · Record page |
Recent recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0660-2026 | Class II | Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and… | Jun 26, 2026 |
| D-0584-2026 | Class II | Niacin Extended-release Tablets, USP, 1,000 mg, 90-count bottles, Rx Only, Distributed by: Lannett… | May 27, 2026 |
| D-0533-2026 | Class III | Primidone Tablets USP, 250mg, 100-count bottle, Rx only, Distributed by: Lannett Company, Inc… | Apr 24, 2026 |
| D-0096-2026 | Class II | Niacin Extended-release Tablets, USP, 1,000 mg, Rx Only, 90 Tablets per bottle, Distributed by… | Oct 10, 2025 |
| D-0642-2025 | Class II | Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine… | Aug 19, 2025 |
| D-0599-2025 | Class II | Lisdexamfetamine Dimesylate Capsules, 40 mg, 100-count bottles, Rx Only, Distributed by: Lannett… | Aug 11, 2025 |
| D-0112-2025 | Class II | Lisdexamfetamine Dimesylate Capsules, 10 mg, 100 Capsules per bottle, Rx only, Distributed by… | Oct 25, 2024 |
| D-0160-2023 | Class III | Triamterene and Hydrochlorothiazide Capsules, USP (37.5 mg/25 mg), Rx Only, 1000 Capsules per… | Nov 9, 2022 |
| D-0161-2023 | Class III | Triamterene and Hydrochlorothiazide Capsules, USP (37.5 mg/25 mg), Rx Only, [100 or 1000 ] Capsules… | Nov 9, 2022 |
| D-0558-2022 | Class II | Diazepam Oral Solution (Concentrate), 25 mg per 5 mL (5 mg/mL), 30 mL BOTTLE and DROPPER, Rx Only… | Feb 9, 2022 |
| D-1508-2020 | Class II | Prednisone Tablets, USP 2.5 mg, 100 tablets, Rx only, Distributed by: Lannett Company, Inc… | Aug 10, 2020 |
| D-0630-2020 | Class I | Levetiracetam Oral Solution 100mg/mL, 473 mL (16 fl. oz.) Bottles, Rx Only, Distributed by: Lannett… | Dec 6, 2019 |
| D-0309-2020 | Class II | Lannett Ranitidine Syrup (Ranitidine Oral Solution, USP), 15mg/mL Rx Only Distributed by: Lannett… | Oct 28, 2019 |
| D-0996-2019 | Class III | Oxybutynin Chloride, Extended-Release Tablets USP, 10 mg, 100 Tablet, Rx Only, Distributed by… | Feb 21, 2019 |
| D-0083-2019 | Class II | HydrOXYzine HYDROCHLORIDE SYRUP (HydrOXYzine Hydrochloride Oral Solution, USP), 10 mg per 5 mL, Rx… | Oct 11, 2018 |
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Oct 21, 2022 | Seymour, IN | Drugs | Voluntary Action Indicated (VAI) | 1819171 |
| Mar 25, 2022 | Philadelphia, PA | Drugs | No Action Indicated (NAI) | 2510865 |
| Jan 25, 2019 | Philadelphia, PA | Drugs | No Action Indicated (NAI) | 2510865 |
| Jul 23, 2018 | Seymour, IN | Food/Cosmetics | Voluntary Action Indicated (VAI) | 1819171 |
| Feb 2, 2018 | Seymour, IN | Drugs | Voluntary Action Indicated (VAI) | 1819171 |
| Jun 22, 2017 | Philadelphia, PA | Drugs | No Action Indicated (NAI) | 2510865 |
| Sep 16, 2016 | Philadelphia, PA | Drugs | Voluntary Action Indicated (VAI) | 2510865 |
| Dec 16, 2014 | Seymour, IN | Drugs | Voluntary Action Indicated (VAI) | 1819171 |
| Aug 15, 2013 | Seymour, IN | Drugs | Voluntary Action Indicated (VAI) | 1819171 |
| Aug 6, 2013 | Philadelphia, PA | Drugs | No Action Indicated (NAI) | 2510865 |
| Oct 31, 2012 | Seymour, IN | Drugs | Official Action Indicated (OAI) | 1819171 |
| Aug 29, 2012 | Seymour, IN | Drugs | Voluntary Action Indicated (VAI) | 1819171 |
| Aug 17, 2012 | Philadelphia, PA | Drugs | Voluntary Action Indicated (VAI) | 2510865 |
| May 13, 2011 | Seymour, IN | Drugs | Voluntary Action Indicated (VAI) | 1819171 |
| Mar 21, 2011 | Philadelphia, PA | Drugs | Voluntary Action Indicated (VAI) | 2510865 |
| Sep 14, 2010 | Philadelphia, PA | Drugs | No Action Indicated (NAI) | 3006174033 |
| Sep 14, 2010 | Philadelphia, PA | Drugs | No Action Indicated (NAI) | 2510865 |
| May 12, 2010 | Seymour, IN | Drugs | Voluntary Action Indicated (VAI) | 1819171 |
| Feb 9, 2010 | Philadelphia, PA | Drugs | Voluntary Action Indicated (VAI) | 2510865 |
| Feb 9, 2010 | Philadelphia, PA | Drugs | Voluntary Action Indicated (VAI) | 2510865 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
Compliance Actions
FDA's compliance actions data lists 1 compliance action under Lannett Company Inc.: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 1819171 | Seymour, IN | 10 | Oct 21, 2022 |
| FEI 2510865 | Philadelphia, PA | 10 | Mar 25, 2022 |
| FEI 3006174033 | Philadelphia, PA | 1 | Sep 14, 2010 |
Lannett Company Inc. and the FDA: common questions
Has Lannett Company Inc. received an FDA warning letter?
Yes. FDA has issued 1 warning letter to Lannett Company Inc.. The most recent is dated Mar 30, 2009.
Has Lannett Company Inc. received an FDA Form 483?
FDA has not published a Form 483 for "Lannett Company Inc." in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect Lannett Company Inc.?
The most recent FDA inspection on file ended Oct 21, 2022 at Seymour, IN and was classified VAI. FDA has 21 inspections of Lannett Company Inc. on file, 1 of them classified OAI (official action indicated).
Has Lannett Company Inc. had an FDA recall?
Yes. Lannett Company Inc. has 15 FDA recalls on record, 1 of them Class I, the most serious class. The most recent started Jun 26, 2026.
Need more than this page shows? Ask about Lannett Company Inc. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.